Hidehiko Shimokawa
Nippon Shinyaku (Japan)(JP)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Pleural and Pulmonary Diseases, Gastric Cancer Management and Outcomes, Medical Imaging and Pathology Studies
Most-Cited Works
- Epithelial-mesenchymal transition in EGFR-TKI acquired resistant lung adenocarcinoma.(2010)
- → Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence(2010)93 cited
- → Preoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I non-small cell lung cancer(2011)82 cited
- → Expression of selected gene for acquired drug resistance to EGFR-TKI in lung adenocarcinoma(2011)80 cited
- Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis.(2011)
- → Results of a Surgical Resection for Patients With Stage IV Non–Small-Cell Lung Cancer(2011)53 cited
- → Clinical Significance of IGF1R Expression in Non–Small-Cell Lung Cancer(2012)52 cited
- → What factors predict recurrence of a spontaneous pneumothorax?(2012)42 cited
- The prognostic significance of HER2 overexpression in non-small cell lung cancer.(2011)
- The expression of Ki-67, but not proliferating cell nuclear antigen, predicts poor disease free survival in patients with adenocarcinoma of the lung.(2011)